MetaCap

Globus Medical (GMED) vs Solventum (SOLV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Solventum (SOLV) has outperformed Globus Medical (GMED) over the past year, gaining 1.9% versus a loss of 22.2%. Solventum is the larger company by market cap ($14.36 billion vs $8.86 billion), about 1.6 times the size, while Globus Medical is growing revenue faster (+16.7% vs +0.9%). On valuation, Solventum trades at a lower forward P/E (11.2x vs 12.5x for Globus Medical).

Solventum converts more of its revenue into profit, with a net margin of 18.7% versus 18.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

GMED-22.24%SOLV+1.93%
+14%-6%-26%
Nov 21, 20251 yearNov 20, 2026
GMED+24.70%SOLV+21.50%
+83%+24%-35%
Mar 25, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

GMED versus SOLV key metrics
MetricGMEDSOLV
Share price$66.89$84.50
Market cap$8.86B$14.36B
1-day change-2.49%-1.52%
YTD return-23.39%+6.64%
1-year return-22.24%+1.93%
5-year return+4.60%—
P/E ratio (TTM)16.4894.94
Forward P/E12.5311.20
EPS (TTM)$4.06$0.89
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$2.94B$8.32B
Revenue growth (YoY)+16.65%+0.86%
Net income (latest FY)$537.87M$1.56B
Gross margin67.41%53.47%
Operating margin16.33%26.20%
Net margin18.30%18.69%
52-week high$101.40$94.16
52-week low$66.63$62.38
Distance from 52-week high-34.03%-10.26%
Analyst consensusbuybuy
Avg. price target upside+39.68%+16.43%
Average volume1.63M1.03M
Shares outstanding110.04M169.96M
Employees6,00020,584
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • SOLV has outperformed GMED by 24.2 percentage points over the past year.
  • Solventum trades at a higher earnings multiple (94.9x vs 16.5x trailing P/E).
  • Globus Medical grew revenue faster in its latest fiscal year (+16.65% vs +0.86%).

About Globus Medical

GMED stock →

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Health Care · Medical/Dental Instruments · 6,000 employees

About Solventum

SOLV stock →

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.

Health Care · Medical/Dental Instruments · 20,584 employees

GMED vs SOLV FAQ

Which is bigger, Globus Medical or Solventum?

Solventum (SOLV) is larger, with a market capitalization of $14.36B compared with $8.86B for Globus Medical (GMED).

Which stock has performed better over the past year, GMED or SOLV?

SOLV returned +1.93% over the past 12 months, compared with -22.24% for GMED (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, GMED or SOLV?

GMED has the lower trailing P/E at 16.5, versus 94.9 for SOLV. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Globus Medical and Solventum in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons